Bolt Biotherapeutics Inc
|Market Cap (Intraday)||566.60M|
|2yr Forward PE||N/A|
Bolt Biotherapeutics Inc Stock, NASDAQ:BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.